Institutional Ownership
Vera Therapeutics Inc
CUSIP 92337R101CL AVERAQ1 2026
13D / 13G Filings
54
Schedule 13D/13G on record
Beneficial Filers
20
Distinct reporting persons
Largest Stake
15.2%
Max % of class reported
Institutional Holders
222
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
54 filings · latest Mar 11, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 11, 2026 | Deep Track Capital, LP | 13G | 5.5% | 3.92M | SEC |
| 2 | Mar 5, 2026 | Sofinnova Venture Partners X, L.P. ("Svp X") | 13D/A | 4.0% | — | SEC |
| 3 | Feb 17, 2026 | T. Rowe Price Associates, Inc. | 13G/A | 7.7% | 5.46M | SEC |
| 4 | Feb 5, 2026 | Fmr LLC | 13G/A | 4.1% | 2.89M | SEC |
| 5 | Jan 30, 2026 | The Vanguard Group | 13G | 5.0% | 3.57M | SEC |
| 6 | Nov 14, 2025 | T. Rowe Price Associates, Inc. | 13G/A | 5.7% | 3.67M | SEC |
| 7 | Aug 14, 2025 | Kynam Capital Management, LP | 13G | 5.4% | 3.43M | SEC |
| 8 | Jun 11, 2025 | Deerfield Mgmt, L.P. | 13G | 5.3% | 3.35M | SEC |
| 9 | Feb 14, 2025 | Avoro Capital Advisors LLC | 13G/A | 8.9% | 5.61M | SEC |
| 10 | Nov 14, 2024 | Commodore Capital LP | 13G/A | 4.5% | 2.48M | SEC |
44 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Vera Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Avoro Capital Advisors LLC | 5.89M | $236.91M |
| 2 | Blackrock, Inc. | 5.09M | $204.69M |
| 3 | Deep Track Capital, LP | 4.11M | $165.19M |
| 4 | Deerfield Management Company, L.P. | 3.72M | $149.74M |
| 5 | Kynam Capital Management, LP | 3.40M | $136.71M |
| 6 | State Street Corp | 3.36M | $135.32M |
| 7 | Sofinnova Investments, Inc. | 2.79M | $112.40M |
| 8 | Fmr LLC | 2.68M | $107.67M |
| 9 | Eversept Partners, LP | 2.17M | $87.43M |
| 10 | Bellevue Group AG | 1.71M | $68.82M |